Zymeworks Inc. Files 8-K on Operations and Financials

Ticker: ZYME · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1937653

Sentiment: neutral

Topics: operations, financials, reporting

TL;DR

Zymeworks dropped an 8-K on Jan 8th covering ops and financials.

AI Summary

Zymeworks Inc. filed an 8-K on January 8, 2025, reporting on its results of operations, other events, and financial statements. The filing details the company's ongoing business activities and financial condition as of the reporting date.

Why It Matters

This 8-K filing provides an update on Zymeworks Inc.'s operational and financial status, which is crucial for investors to assess the company's performance and outlook.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting operational and financial information, not indicating any immediate or significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Zymeworks Inc.?

The primary purpose of this 8-K filing is to report on Zymeworks Inc.'s results of operations and financial condition, as well as other events and financial statements.

On what date was this 8-K report filed or effective?

The report was filed as of January 8, 2025.

What is Zymeworks Inc.'s state of incorporation?

Zymeworks Inc. is incorporated in Delaware.

What is the address of Zymeworks Inc.'s principal executive offices?

The address of Zymeworks Inc.'s principal executive offices is 108 Patriot Drive, Suite A, Middletown, Delaware 19709.

What is Zymeworks Inc.'s telephone number?

Zymeworks Inc.'s telephone number, including area code, is (302) 274-8744.

Filing Stats: 982 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2025-01-08 16:16:05

Key Financial Figures

Filing Documents

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements are identified by such words as "believe," "expect," "anticipate" and words of similar import and are based on current expectations that involve risks and uncertainties, such as the Company's plans, projections, objectives, expectations and intentions. All statements other than historical or current facts are forward-looking statements, including, without limitation, statements about the Company's preliminary and unaudited estimate of cash resources, which consist of cash, cash equivalents and marketable securities, and the Company's anticipated funding of its current operations and related expected timelines. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. These statements, like all statements in this report, speak only as of their date. Furthermore, the Company is in the process of finalizing its financial results for the fourth quarter and fiscal year ended December 31, 2024, and therefore the Company's finalized and audited results and final analysis of those results are not yet available. The preliminary expectations regarding year-end cash, cash equivalents, and marketable securities are the responsibility of management, are subject to management's review and actual results could differ from management's expectations. The actual results are also subject to audit by the Company's independent registered public accounting firm and no assurance is given by the Company's independent registered public accounting firm on such preliminary expectations. You should not draw any conclusions as to any other financial results as of and for the year ended December 31, 2024, based on the foregoing estimates. Ite

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ZYMEWORKS INC. (Registrant) Date: January 8, 2025 By: /s/ Kenneth Galbraith Name: Title: Kenneth Galbraith Chair of the Board of Directors, President and Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing